NEW YORK (GenomeWeb News) — Oxford Gene Technology today said it has granted UK biotech MassTag Technologies licensing rights to its Tridend technology.
 
The company said the option on the license will become exclusive when MassTag completes a fund-raising campaign. Also through the agreement, OGT will become a minority shareholder in MassTag.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.